Chris Aiken, MD

CLINICAL UPDATE

Generic Lurasidone Shifts the Balance in Bipolar Depression

June 1, 2025

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Lurasidone was heralded as a game changer when it first gained FDA approval for bipolar depression in 2013. In 2023, this article covers what that means for patients with bipolar disorder and schizophrenia who can now afford its $10–$20/month cost.

Cobenfy: A New Antipsychotic

June 1, 2025

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Last fall, the FDA approved xanomeline/trospium (Cobenfy) for adults with schizophrenia. Here's a closer look at this treatment.

Should You Test MTHFR?

May 5, 2025

Chris Aiken, MD and Kellie Newsome, PMHNP

MTHFR is a genetic test that aims to clarify who will respond to methylfolate in depression. But is it worth testing for?

Psych Meds That Cause Weight Loss

May 1, 2025

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Some patients will only take a psych med that is weight neutral. We found nine that can cause weight loss.

Folate and Depression

April 28, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

We learn how psychiatrists figured out that low folate causes depression, and how the vitamin can treat depression even when serum levels are normal.

Folate, Valproate, and Lamotrigine

April 21, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

We interview Victor Hoffbrand on the discovery of folate and look at how this vitamin can help or harm the action of anticonvulsants in bipolar disorder.

A Scam for Every Woman, Child, and Man: Part 2

April 14, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about the therapeutic techniques to break psychological trap.

A Scam for Every Woman, Child, and Man: Part 1

April 7, 2025

Kellie Newsome, PMHNP and Chris Aiken, MD

1 in 3 Americans were victims of online scams in the past year. Learn the signs, and the psychological traps that can make people lose everything.

Clinical Update

New Weight Loss Drugs in Psychiatry

April 1, 2025

Chris Aiken, MD and David Liebers, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

David Liebers, MD. Psychiatry resident at NYU Langone, Department of Psychiatry.

Drs. Aiken and Liebers have no financial relationships with companies related to this material.

From liraglutide (Saxenda) to tirzepatide (Mounjaro), new weight loss medications are reshaping the treatment of diabetes and obesity. But what’s their impact in psychiatry?